Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: How to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale

Journal of Infectious Diseases

Volumn 183, Issue 9, 2001, Pages 1311-1317

  Yahi, Nouara ^a   Fantini, Jacques ^a   Tourres, Christian ^a   Tivoli, Natacha ^a   Koch, Nathalie ^a   Tamalet, Catherine ^a  

^a Fac des Sciences de Marseille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DATA BASE; ENVELOPE GENE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; THERAPY RESISTANCE; VIRUS MUTATION;

ADOLESCENT; ADULT; AGED; CLUSTER ANALYSIS; COHORT STUDIES; DRUG RESISTANCE; FEMALE; FRANCE; GENES, ENV; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS; VARIATION (GENETICS);

EID: 0035341915     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/319859     Document Type: Article

References (25)

1. HIV-1 subtypes: Implications for epidemiology, pathogenicity, vaccines and diagnostics. Workshop Report from the EU Commission (DG XII, INCO-DC) and the Joint United Nations Programmed on HIV/AIDS
2. The puzzle of HIV-I subtypes in Africa
3. Neutralisation of HIV-1 sub-types: Implications for vaccine formulations
4. HIV-1 diversity in France, 1996-1998: The AC 11 laboratory network
5. Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995)
6. Impact of HIV type 1 subtype variation on viral RNA quantitation
7. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain
8. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study
9. Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: Survey of 787 sequences
10. A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance
11. Multidrug resistance genotypes (insertions in the β3-β4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: Incidence and association with other resistance mutations
12. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA panel
13. Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe
14. Rapid molecular epidemiology of human immunodeficiency virus transmission
15. Update proposal of reference sequences of HIV-1 genetic subtypes
16. Multiple sequence alignment with Clustal X
17. Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic
18. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays
19. pol gene diversity of five human immunodeficiency virus type 1 subtypes: Evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D
20. Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide
21. Clinical implications of identifying non-B subtypes of human immunodeficiency virus type 1 infection
22. Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors
23. Use of a drug resistance sequence database to determine the prevalence of non-subtype B HIV-1 infections in US and European clinical cohorts
24. Human immunodeficiency virus reverse transcriptase and protease sequence database